Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-15 Sale |
2025-04-16 5:00 pm |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
8,500 | $9.5659 | $81,310 | 460,642 (Direct) |
View |
| 2025-03-14 Sale |
2025-03-17 5:00 pm |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
8,500 | $10.85 | $92,205 | 469,142 (Direct) |
View |
| 2025-03-12 Purchase |
2025-03-13 5:13 pm |
Rapport Therapeutics Inc. | RAPP | Ignelzi Troy A. Chief Financial Officer |
10,000 | $10.1 | $100,988 | 10,000 (Direct) |
View |
| 2025-03-12 Purchase |
2025-03-13 5:00 pm |
Rapport Therapeutics Inc. | RAPP | Young Wendy B. Director |
6,000 | $10.21 | $61,250 | 6,000 (Direct) |
View |
| 2024-07-01 Purchase |
2024-07-03 8:04 pm |
Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director |
44,032 | $24.52 | $1,079,575 | 1,922,819 (Indirect) |
View |
| 2024-06-10 Purchase |
2024-06-10 7:38 pm |
Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director |
558,824 | $17 | $9,500,008 | 25,455 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Option Award |
2025-04-03 5:00 pm |
N/A 2035-04-01 |
Rapport Therapeutics Inc. | RAPP | Sevigny Jeffrey Chief Medical Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2025-03-03 Option Award |
2025-03-05 5:00 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer |
13,987 | $0 | 171,928 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:30 pm |
N/A 2035-02-03 |
Rapport Therapeutics Inc. | RAPP | Ignelzi Troy A. Chief Financial Officer |
142,000 | $0 | 142,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:30 pm |
N/A 2035-02-03 |
Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:30 pm |
N/A 2035-02-03 |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:30 pm |
N/A 2035-02-03 |
Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer |
428,000 | $0 | 428,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 5:30 pm |
N/A 2035-02-03 |
Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operating Officer |
129,000 | $0 | 129,000 (Direct) |
View |
| 2024-11-07 Option Award |
2024-11-07 7:00 pm |
N/A 2034-11-07 |
Rapport Therapeutics Inc. | RAPP | Young Wendy B. Director |
29,756 | $0 | 29,756 (Direct) |
View |
| 2024-11-07 Option Award |
2024-11-07 7:00 pm |
N/A 2034-11-07 |
Rapport Therapeutics Inc. | RAPP | PEREZ ROBERT J Director |
29,756 | $0 | 29,756 (Direct) |
View |
| 2024-11-07 Option Award |
2024-11-07 6:59 pm |
N/A 2034-11-07 |
Rapport Therapeutics Inc. | RAPP | Silva Paul M Director |
29,756 | $0 | 29,756 (Direct) |
View |
| 2024-11-07 Option Award |
2024-11-07 6:47 pm |
N/A 2034-11-07 |
Rapport Therapeutics Inc. | RAPP | Sanchez Ramiro Director |
29,756 | $0 | 29,756 (Direct) |
View |
Ownership |
2024-11-07 6:27 pm |
N/A 2033-12-05 |
Rapport Therapeutics Inc. | RAPP | Young Wendy B. Director |
0 | $0 | 2,335 (Direct) |
View |
| 2024-06-10 Conversion |
2024-06-10 7:46 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
35,652,876 | $0 | 3,728,738 (Indirect) |
View |
| 2024-06-06 Option Award |
2024-06-10 7:44 pm |
N/A 2034-06-05 |
Rapport Therapeutics Inc. | RAPP | Galer Bradley S. Chief Medical Officer |
123,818 | $0 | 123,818 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 7:43 pm |
N/A 2034-06-05 |
Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operations Officer |
88,442 | $0 | 88,442 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 7:43 pm |
N/A 2034-06-05 |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
28,302 | $0 | 28,302 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 7:42 pm |
N/A 2034-06-05 |
Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer |
84,904 | $0 | 84,904 (Direct) |
View |
| 2024-06-10 Conversion |
2024-06-10 7:42 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner |
71,909,947 | $0 | 8,104,451 (Direct) |
View |
| 2024-06-06 Option Award |
2024-06-10 7:39 pm |
N/A 2034-06-05 |
Rapport Therapeutics Inc. | RAPP | Ceesay Abraham Chief Executive Officer |
530,647 | $0 | 530,647 (Direct) |
View |
| 2024-06-10 Conversion |
2024-06-10 7:38 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director |
13,316,876 | $0 | 25,455 (Indirect) |
View |
| 2024-06-06 Option Award |
2024-06-10 7:35 pm |
N/A 2034-06-05 |
Rapport Therapeutics Inc. | RAPP | Ignelzi Troy A. Chief Financial Officer |
81,366 | $0 | 81,366 (Direct) |
View |
Ownership |
2024-06-06 7:14 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH NELSEN ROBERT Burow Kristina GILLIS STEVEN 10% Owner |
0 | $0 | 3,728,738 (Indirect) |
View |
Ownership |
2024-06-06 7:07 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | Galer Bradley S. Chief Medical Officer |
0 | $0 | 290,861 (Direct) |
View |
Ownership |
2024-06-06 7:04 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | Gault Cheryl Chief Operations Officer |
0 | $0 | 290,861 (Direct) |
View |
Ownership |
2024-06-06 7:03 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | HEALY JAMES Director |
0 | $0 | 1,392,738 (Indirect) |
View |
Ownership |
2024-06-06 7:03 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | Bredt David Chief Scientific Officer |
0 | $0 | 673,624 (Direct) |
View |
Ownership |
2024-06-06 6:59 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | Yeleswaram Krishnaswamy Chief Development Officer |
0 | $0 | 432,747 (Direct) |
View |
Ownership |
2024-06-06 6:57 pm |
N/A N/A |
Rapport Therapeutics Inc. | RAPP | Third Rock Ventures V L.P. Third Rock Ventures GP V LP TRV GP V LLC Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC 10% Owner |
0 | $0 | 8,104,451 (Direct) |
View |
Ownership |
2024-06-06 6:56 pm |
N/A 2034-03-24 |
Rapport Therapeutics Inc. | RAPP | MARAGANORE JOHN Director |
0 | $0 | 87,567 (Direct) |
View |